These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 16036434)

  • 1. Biochemical characterization of plasma in amyotrophic lateral sclerosis: amino acid and protein composition.
    Palma A; de Carvalho M; Barata N; Evangelista T; Chicau P; Regalla M; Costa J
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2005 Jun; 6(2):104-10. PubMed ID: 16036434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma amino acids concentration in amyotrophic lateral sclerosis patients.
    Iłzecka J; Stelmasiak Z; Solski J; Wawrzycki S; Szpetnar M
    Amino Acids; 2003 Jul; 25(1):69-73. PubMed ID: 12836061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma amino acids percentages in amyotrophic lateral sclerosis patients.
    Iłzecka J; Stelmasiak Z; Solski J; Wawrzycki S; Szpetnar M
    Neurol Sci; 2003 Nov; 24(4):293-5. PubMed ID: 14658054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal glutamate metabolism in amyotrophic lateral sclerosis.
    Plaitakis A; Caroscio JT
    Ann Neurol; 1987 Nov; 22(5):575-9. PubMed ID: 2892463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of riluzole (Rilutek) treatment on plasma amino acid percentages in amyotrophic lateral sclerosis patients.
    Iłzecka J; Stelmasiak Z; Solski J; Wawrzycki S; Szpetnar M
    Neurol Sci; 2003 Nov; 24(4):290-2. PubMed ID: 14658053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated plasma homocysteine levels in patients with amyotrophic lateral sclerosis.
    Zoccolella S; Simone IL; Lamberti P; Samarelli V; Tortelli R; Serlenga L; Logroscino G
    Neurology; 2008 Jan; 70(3):222-5. PubMed ID: 18195267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscle growth and plasma concentrations of amino acids, insulin-like growth factor-I, and insulin in growing pigs fed reduced-protein diets.
    Guay F; Trottier NL
    J Anim Sci; 2006 Nov; 84(11):3010-9. PubMed ID: 17032795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma glutamate and glycine levels in patients with amyotrophic lateral sclerosis.
    Andreadou E; Kapaki E; Kokotis P; Paraskevas GP; Katsaros N; Libitaki G; Petropoulou O; Zis V; Sfagos C; Vassilopoulos D
    In Vivo; 2008; 22(1):137-41. PubMed ID: 18396796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic analysis of plasma from Portuguese patients with familial amyotrophic lateral sclerosis.
    Palma AS; De Carvalho M; Grammel N; Pinto S; Barata N; Conradt HS; Costa J
    Amyotroph Lateral Scler; 2008 Dec; 9(6):339-49. PubMed ID: 18608108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid erythropoietin (EPO) in amyotrophic lateral sclerosis.
    Brettschneider J; Widl K; Schattauer D; Ludolph AC; Tumani H
    Neurosci Lett; 2007 Apr; 416(3):257-60. PubMed ID: 17368721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased cerebrospinal fluid cytochrome c levels in patients with amyotrophic lateral sclerosis.
    Iłzecka J
    Scand J Clin Lab Invest; 2007; 67(3):264-9. PubMed ID: 17454840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid Flt3 ligand level in patients with amyotrophic lateral sclerosis.
    Iłzecka J
    Acta Neurol Scand; 2006 Sep; 114(3):205-9. PubMed ID: 16911350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma glutamate and glycine levels in patients with amyotrophic lateral sclerosis: the effect of riluzole treatment.
    Andreadou E; Kapaki E; Kokotis P; Paraskevas GP; Katsaros N; Libitaki G; Zis V; Sfagos C; Vassilopoulos D
    Clin Neurol Neurosurg; 2008 Mar; 110(3):222-6. PubMed ID: 18055102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fetal olfactory ensheathing cells transplantation in amyotrophic lateral sclerosis patients: a controlled pilot study.
    Huang H; Chen L; Xi H; Wang H; Zhang J; Zhang F; Liu Y
    Clin Transplant; 2008; 22(6):710-8. PubMed ID: 18673377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serine proteases purified from sera of patients with amyotrophic lateral sclerosis (ALS) induce contrasting cytopathology in murine motoneurones to IgG.
    Demestre M; Howard RS; Orrell RW; Pullen AH
    Neuropathol Appl Neurobiol; 2006 Apr; 32(2):141-56. PubMed ID: 16599943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of signal transducer and activator of transcription-3 in the spinal cord of sporadic amyotrophic lateral sclerosis patients.
    Shibata N; Kakita A; Takahashi H; Ihara Y; Nobukuni K; Fujimura H; Sakoda S; Sasaki S; Iwata M; Morikawa S; Hirano A; Kobayashi M
    Neurodegener Dis; 2009; 6(3):118-26. PubMed ID: 19372705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased serum-soluble TRAIL levels in patients with amyotrophic lateral sclerosis.
    Iłzecka J
    Acta Neurol Scand; 2008 May; 117(5):343-6. PubMed ID: 17995989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RANTES levels are elevated in serum and cerebrospinal fluid in patients with amyotrophic lateral sclerosis.
    Rentzos M; Nikolaou C; Rombos A; Boufidou F; Zoga M; Dimitrakopoulos A; Tsoutsou A; Vassilopoulos D
    Amyotroph Lateral Scler; 2007 Oct; 8(5):283-7. PubMed ID: 17852013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma amino acids patterns and age of onset of amyotrophic lateral sclerosis.
    Cecchi M; Messina P; Airoldi L; Pupillo E; Bandettini di Poggio M; Calvo A; Filosto M; Lunetta C; Mandrioli J; Pisa F; Pastorelli R; Beghi E;
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Sep; 15(5-6):371-5. PubMed ID: 24904978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Survival in amyotrophic lateral sclerosis].
    Alcaz S; Jarebinski M; Pekmezović T; Marinković Z; Apostolski S
    Srp Arh Celok Lek; 1997; 125(1-2):19-23. PubMed ID: 17974351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.